Literature DB >> 1409384

Corticosteroid pharmacodynamic modeling: osteocalcin suppression by prednisolone.

J A Wald1, W J Jusko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409384     DOI: 10.1023/a:1015875016041

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  5 in total

Review 1.  Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

Authors:  A Sharma; W J Jusko
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

2.  Comparison of four basic models of indirect pharmacodynamic responses.

Authors:  N L Dayneka; V Garg; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

Review 3.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men.

Authors:  E F L Dubois; M G M Derks; D H Schweitzer; A H Zwinderman; P N R Dekhuijzen; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  2004-05-19       Impact factor: 2.953

5.  Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men.

Authors:  E F L Dubois; M G M Derks; A H Zwinderman; P N R Dekhuijzen; C J Van Boxtel; D H Schweitzer
Journal:  Eur J Clin Pharmacol       Date:  2003-02-15       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.